Stivarga 40 mg Alternative – Regora (Regorafenib) 40 mg Tablet | Beacon Pharmaceuticals

Regora 40 mg (Regorafenib) Tablet by Beacon Pharmaceuticals. Reference brand: Stivarga. multikinase inhibitor; used in selected previously treated colorectal cancer, GIST and liver cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Ibrance 125 mg Alternative – Palker (Palbociclib) 125 mg Capsule | Beacon Pharmaceuticals

Palker 125 mg (Palbociclib) Capsule by Beacon Pharmaceuticals. Reference brand: Ibrance. CDK4/6 inhibitor; used in selected HR-positive, HER2-negative breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Tagrisso 80 mg Alternative – Ositag (Osimertinib) 80 mg Tablet | Beacon Pharmaceuticals

Ositag 80 mg (Osimertinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tagrisso. EGFR inhibitor; used in selected EGFR-mutated lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Lynparza 150 mg Alternative – Olapar (Olaparib) 150 mg Tablet | Beacon Pharmaceuticals

Olapar 150 mg (Olaparib) Tablet by Beacon Pharmaceuticals. Reference brand: Lynparza. PARP inhibitor; used in selected ovarian, breast, pancreatic and prostate cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Lynparza 100 mg Alternative – Olapar (Olaparib) 100 mg Tablet | Beacon Pharmaceuticals

Olapar 100 mg (Olaparib) Tablet by Beacon Pharmaceuticals. Reference brand: Lynparza. PARP inhibitor; used in selected ovarian, breast, pancreatic and prostate cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Zejula 100 mg Alternative – Nirova (Niraparib) 100 mg Capsule | Beacon Pharmaceuticals

Nirova 100 mg (Niraparib) Capsule by Beacon Pharmaceuticals. Reference brand: Zejula. PARP inhibitor; used in selected ovarian cancer maintenance settings. Prescription medicine. Brand comparison does not establish interchangeability.

Lonsurf 20 mg Alternative – Loncil (Trifluridine / Tipiracil) 20 mg Tablet | Beacon Pharmaceuticals

Loncil 20 mg (Trifluridine / Tipiracil) Tablet by Beacon Pharmaceuticals. Reference brand: Lonsurf. oral antineoplastic combination; used in selected previously treated metastatic colorectal cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Lonsurf 15 mg Alternative – Loncil (Trifluridine / Tipiracil) 15 mg Tablet | Beacon Pharmaceuticals

Loncil 15 mg (Trifluridine / Tipiracil) Tablet by Beacon Pharmaceuticals. Reference brand: Lonsurf. oral antineoplastic combination; used in selected previously treated metastatic colorectal cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Femara 2.5 mg Alternative – Lexel (Letrozole) 2.5 mg Tablet | Beacon Pharmaceuticals

Lexel 2.5 mg (Letrozole) Tablet by Beacon Pharmaceuticals. Reference brand: Femara. aromatase inhibitor; used in selected hormone receptor-positive breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Lenvima 10 mg Alternative – Lenva (Lenvatinib) 10 mg Capsule | Beacon Pharmaceuticals

Lenva 10 mg (Lenvatinib) Capsule by Beacon Pharmaceuticals. Reference brand: Lenvima. multikinase inhibitor; used in selected thyroid, kidney, liver and endometrial cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Lenvima 4 mg Alternative – Lenva (Lenvatinib) 4 mg Capsule | Beacon Pharmaceuticals

Lenva 4 mg (Lenvatinib) Capsule by Beacon Pharmaceuticals. Reference brand: Lenvima. multikinase inhibitor; used in selected thyroid, kidney, liver and endometrial cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Gleevec 400 mg Alternative – Imanix (Imatinib) 400 mg Tablet | Beacon Pharmaceuticals

Imanix 400 mg (Imatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gleevec. BCR-ABL/KIT inhibitor; used in selected chronic myeloid leukemia and gastrointestinal stromal tumors. Prescription medicine. Brand comparison does not establish interchangeability.